Assessment of Bone Mineral Density in Patients With Subclinical Hypothyroidism
NCT ID: NCT04270110
Last Updated: 2020-02-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2020-01-01
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Subclinical Hypothyroidism on Liver Enzymes and Lipid Profile
NCT07236697
Hypothyroidism in Patients With Type 2 Diabetes With Early Diabetic Nephropathy
NCT03178253
Study of Chronic Fatigue, Depression, and Anxiety Among Hypothyroid Patients Attending Assuit University Hospitals
NCT06660888
Evaluation of the Pattern of Thyroid Dysfunctions in Patients With Metabolic Syndrome
NCT03214068
Early Detection of Endolymphatic Hydrops in Hypothyroid Patients
NCT05334771
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* There are a lot of endocrinological reasons of secondary osteoporosis (for example: Cushing's syndrome, hyperparathyroidism, hypogonadism, acromegaly, diabetes mellitus, hypothyroidism etc..
Any changes of normal thyroid function and Thyroid stimulating hormones (TSH) directly affects the remodeling of bone through TSH receptor found on osteoblast and osteoclast precursor cells.
TSH has a positive correlation with body mass index (BMI) in women; though, this correlation is insignificant in male. Women having subclinical hypothyroidism have reduced femoral neck bone mineral density (BMD). The variations in thyroid function are primary, while changes in body weight and bones are secondary. The physiological variation of thyroid hormones is associated with changes in BMD and non vertebral fracture risk in healthy postmenopausal women.
The definition of osteoporosis by the world health organization (WHO) is densitometric and non-clinical and is based on the measurement of bone mass and dexa method in the spine or hip. There is still controversy about the relation between thyroid hormones, osteoporosis and BMD in female hypothyroid patients. This study aims to fill the gaps in our understanding of impact of subclinical hypothyroid disorder on bone densitometry.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Case
Patients with subclinical hypothyroidism
No interventions assigned to this group
Control
Patients with Normal thyroid function
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Cushing
* hyperparathrodisim
* CKD .patients on corticosteroid therapy.
* Inflammatory conditions as rheumatoid arthritis,Systemic Lupus, Crohn's disease, ulcerative colitis
* Haematological conditions as multiple myeloma, Myeloproliferative disorders
* Vitamin D deficiency
* Males aged more than 55 years old
* Postmenopausal females will also be excluded in this study
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
kareem mohammed mohammed
resident doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assiut university Hospital
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Kareem Mohammed, Master
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Lakatos P. Thyroid hormones: beneficial or deleterious for bone? Calcif Tissue Int. 2003 Sep;73(3):205-9. doi: 10.1007/s00223-002-0027-8.
Related Links
Access external resources that provide additional context or updates about the study.
Thyroid Hormones: Beneficial or Deleterious for Bone?
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
assessmentofbonemineral
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.